|
Hypertrophy
Citations 271-280 of 489 total displayed.
|
Past content
(since Jan 1999):
|
- Basic Science Reports
Thioredoxin-Interacting Protein Controls Cardiac Hypertrophy Through Regulation of Thioredoxin Activity
- Jun Yoshioka, P. Christian Schulze, Mihaela Cupesi, Jeremy D. Sylvan, Catherine MacGillivray, Joseph Gannon, Hayden Huang, and Richard T. Lee
Circulation 2004;109:2581-2586; published online before print as doi:10.1161/01.CIR.0000129771.32215.44
[Abstract]
[Full text]
- Articles
Thioredoxin-Interacting Protein Controls Cardiac Hypertrophy Through Regulation of Thioredoxin Activity
- Jun Yoshioka, P. Christian Schulze, Mihaela Cupesi, Jeremy D. Sylvan, Catherine MacGillivray, Joseph Gannon, Hayden Huang, and Richard T. Lee
Circulation published May 3, 2004, doi:10.1161/01.CIR.0000129771.32215.44
[Abstract]
- Basic Science Reports
Protective Effects of Endogenous Adrenomedullin on Cardiac Hypertrophy, Fibrosis, and Renal Damage
- Pei Niu, Takayuki Shindo, Hiroshi Iwata, Satoshi Iimuro, Norifumi Takeda, Yuelan Zhang, Aya Ebihara, Yoshihiro Suematsu, Kenji Kangawa, Yasunobu Hirata, and Ryozo Nagai
Circulation 2004;109:1789-1794; published online before print as doi:10.1161/01.CIR.0000118466.47982.CC
[Abstract]
[Full text]
- Review: Current Perspective
Hypertrophy of the Heart: A New Therapeutic Target?
- Norbert Frey, Hugo A. Katus, Eric N. Olson, and Joseph A. Hill
Circulation 2004;109:1580-1589, doi:10.1161/01.CIR.0000120390.68287.BB
[Abstract]
[Full text]
- Basic Science Reports
Aldosterone, Through Novel Signaling Proteins, Is a Fundamental Molecular Bridge Between the Genetic Defect and the Cardiac Phenotype of Hypertrophic Cardiomyopathy
- Natalia Tsybouleva, Lianfeng Zhang, Suetnee Chen, Rajnikant Patel, Silvia Lutucuta, Shintaro Nemoto, Gilberto DeFreitas, Mark Entman, Blase A. Carabello, Robert Roberts, and A.J. Marian
Circulation 2004;109:1284-1291; published online before print as doi:10.1161/01.CIR.0000121426.43044.2B
[Abstract]
[Full text]
- Clinical Investigations and Reports
Usefulness of B-Type Natriuretic Peptide Assay in the Assessment of Symptomatic State in Hypertrophic Cardiomyopathy
- Barry J. Maron, Venkatakrishna N. Tholakanahalli, Andrey G. Zenovich, Susan A. Casey, Daniel Duprez, Dorothee M. Aeppli, and Jay N. Cohn
Circulation 2004;109:984-989; published online before print as doi:10.1161/01.CIR.0000117098.75727.D8
[Abstract]
[Full text]
- Basic Science Reports
Aldosterone, Through Novel Signaling Proteins, Is a Fundamental Molecular Bridge Between the Genetic Defect and the Cardiac Phenotype of Hypertrophic Cardiomyopathy
- Natalia Tsybouleva, Lianfeng Zhang, Suetnee Chen, Rajnikant Patel, Silvia Lutucuta, Shintaro Nemoto, Gilberto DeFreitas, Mark Entman, Blase A. Carabello, Robert Roberts, and A. J. Marian
Circulation published March 1, 2004, doi:10.1161/01.CIR.0000121426.43044.2B
[Abstract]
[Full text]
- Correspondence
Role of Leptin in the Development of Cardiac Hypertrophy in Experimental Animals and Humans • Response
- Nicholas A. Tritos, Warren J. Manning, Peter G. Danias, Lili A. Barouch, Dan E. Berkowitz, Robert W. Harrison, Christopher P. O’Donnell, and Joshua M. Hare
Circulation 2004;109:e67, doi:10.1161/01.CIR.0000116424.65485.67
[Full text]
- Articles
Protective Effects of Endogenous Adrenomedullin on Cardiac Hypertrophy, Fibrosis, and Renal Damage
- Pei Niu, Takayuki Shindo, Hiroshi Iwata, Satoshi Iimuro, Norifumi Takeda, Yuelan Zhang, Aya Ebihara, Yoshihiro Suematsu, Kenji Kangawa, Yasunobu Hirata, and Ryozo Nagai
Circulation published February 16, 2004, doi:10.1161/01.CIR.0000118466.47982.CC
[Abstract]
- Articles
Usefulness of B-Type Natriuretic Peptide Assay in the Assessment of Symptomatic State in Hypertrophic Cardiomyopathy
- Barry J. Maron, Venkatakrishna N. Tholakanahalli, Andrey G. Zenovich, Susan A. Casey, Daniel Duprez, Dorothee M. Aeppli, and Jay N. Cohn
Circulation published February 16, 2004, doi:10.1161/01.CIR.0000117098.75727.D8
[Abstract]
|
|
